USA Financial Formulas Takes $478,000 Position in Ventas, Inc. $VTR

USA Financial Formulas acquired a new position in shares of Ventas, Inc. (NYSE:VTR) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor acquired 5,846 shares of the real estate investment trust’s stock, valued at approximately $478,000.

Several other hedge funds have also modified their holdings of the stock. Capital World Investors acquired a new position in Ventas during the fourth quarter worth approximately $594,116,000. Norges Bank acquired a new position in shares of Ventas in the 4th quarter valued at $474,571,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Ventas by 32,509.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,648,776 shares of the real estate investment trust’s stock valued at $359,722,000 after purchasing an additional 4,634,520 shares during the last quarter. Cohen & Steers Inc. grew its stake in shares of Ventas by 228.1% during the 4th quarter. Cohen & Steers Inc. now owns 4,606,355 shares of the real estate investment trust’s stock valued at $356,440,000 after buying an additional 3,202,323 shares during the period. Finally, Daiwa Securities Group Inc. grew its stake in shares of Ventas by 188.7% during the 4th quarter. Daiwa Securities Group Inc. now owns 4,705,591 shares of the real estate investment trust’s stock valued at $364,119,000 after buying an additional 3,075,450 shares during the period. 94.18% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Ventas

In other news, Director Michael J. Embler bought 2,500 shares of the firm’s stock in a transaction dated Wednesday, June 3rd. The stock was acquired at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the purchase, the director owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This trade represents a 14.97% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.53% of the company’s stock.

Ventas Stock Up 1.3%

Shares of NYSE:VTR opened at $91.48 on Friday. The company has a market capitalization of $46.92 billion, a price-to-earnings ratio of 169.40, a price-to-earnings-growth ratio of 2.11 and a beta of 0.69. The company has a 50 day moving average of $90.45 and a two-hundred day moving average of $86.54. Ventas, Inc. has a 52-week low of $66.38 and a 52-week high of $101.60. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Evercore restated an “outperform” rating and set a $95.00 price objective on shares of Ventas in a report on Wednesday, April 29th. Wells Fargo & Company lifted their target price on Ventas from $93.00 to $96.00 and gave the company an “overweight” rating in a report on Monday, June 1st. Citigroup boosted their price target on Ventas from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Tuesday, August 4th. Barclays started coverage on Ventas in a research note on Tuesday, July 7th. They set an “equal weight” rating and a $99.00 price target for the company. Finally, Mizuho raised their price objective on Ventas from $98.00 to $104.00 and gave the stock an “outperform” rating in a report on Wednesday, July 22nd. Fifteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $98.00.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.